Home > Insider Trading > Filing (0001209191-20-044542)

Filing Details

Accession Number:: 0001209191-20-044542
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-03 17:54:44
Reporting Period:: 2020-07-30

Accepted Time:: 2020-08-03 17:54:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1540755	Anaplan Inc.	PLAN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1476070	Jr H David Morton	50 Hawthorne Street San Francisco CA 94105	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-07-30	25,099	$45.05	30,620	No	4	S	Direct
Common Stock	Acquisiton	2020-07-30	4,901	$11.86	35,521	No	4	M	Direct
Common Stock	Disposition	2020-07-30	4,901	$45.07	30,620	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-07-30	4,901	$0.00	4,901	$11.86

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
144,064		2028-09-13	No	4	M	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45 to $45.21, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
The Form 4 filed by the Reporting Person on June 12, 2020, inadvertently overstated the number of securities beneficially owned by the Reporting Person by 282 shares of common stock. The total reported in Column 5 corrects for that overstatement.
This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45 to $45.18, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
25% of the stock option vested on September 10, 2019, with the remainder exercisable in 36 equal monthly installments thereafter provided that the Reporting Person remains in continuous service on each vesting date; the option may also be exercised early subject to Issuer's right of repurchase.